Tobacco quitline engagement and outcomes among primary care patients reporting use of tobacco or dual tobacco and cannabis: An observational study.

Tobacco quitline engagement and outcomes among primary care patients reporting use of tobacco or dual tobacco and cannabis: An observational study.
复制标题

报告使用烟草或双重烟草和大麻的初级保健患者的戒烟热线参与度和结果:一项观察性研究。

DOI:
10.1080/08897077.2020.1846665
复制
发表时间:
2021
期刊:
影响因子:
3.5
通讯作者:
Lapham,Gwen
Lapham,Gwen
中科院分区:
医学3区
文献类型:
--
作者:
McClure,JenniferB;Lapham,Gwen

文献摘要

相似文献

背景 烟草和大麻的双重使用越来越普遍,但尚不清楚它如何影响个人戒烟的兴趣或能力。如果双重使用者未能参与治疗或治疗结果较差,则表明烟草治疗方案可能需要根据大麻和烟草使用者的具体需求进行调整。方法我们使用成年人(18岁及以上)的电子治疗记录进行了一项观察性研究,这些成年人(a)在华盛顿州的地区医疗保健系统中注册,(b)从2016年7月至2018年12月通过保险覆盖的戒烟热线寻求戒烟治疗,以及(c)在电子健康记录 (EHR) 中记录的戒烟热线登记期间 (n= 1,390)。治疗参与度是根据戒烟热线咨询电话和完成的网络登录总数来定义的。戒烟线登记后 6 个月对点流行的自我报告戒烟情况进行评估。 结果 32% 的参与者 (n= 441) 报告在观察期间双重使用烟草和任何大麻; 9.4% (n= 130) 报告每天吸食大麻。在报告每日使用大麻的双重使用者中,13.9% 的人在 EHR 中诊断出大麻使用者障碍。在仅使用烟草的人和双重使用组(即使用任何大麻或每日大麻的人)之间,参与戒烟热线咨询和长期戒烟率都没有差异。结论在初级保健中的吸烟者和参加戒烟热线护理的吸烟者中,烟草和大麻的双重使用很常见,但这可能不会影响烟草戒烟热线的参与或戒烟。美国存在利用戒烟热线来识别和干预烟草和大麻双重使用者的机会。亮点•烟草戒烟热线护理在烟草使用者和烟草和大麻双重使用者中同样具有参与性和有效性•许多日常拨打烟草戒烟热线的大麻使用者可能患有大麻使用障碍•可以利用烟草戒烟热线来识别和干预烟草和大麻双重使用者
BackgroundDual use of tobacco and cannabis is increasingly common, but it is unclear how it impacts individuals’ interest in or ability to stop smoking. If dual users fail to engage in treatment or have worse treatment outcomes, it would suggest that tobacco treatment programs may need to be tailored to the specific needs of those using cannabis and tobacco.MethodsWe conducted an observational study using electronic treatment records from adults (18 years and older) who (a) were enrolled in a regional healthcare system in Washington state, (b) sought tobacco cessation treatment through an insurance-covered quitline from July 2016 to December 2018 and (c) had cannabis use frequency during the period of their quitline enrollment documented in their electronic health record (EHR) (n= 1,390). Treatment engagement was defined by the total number of quitline counseling calls and web-logins completed. Point prevalent self-reported tobacco abstinence was assessed 6 months post-quitline enrollment.ResultsThirty-two percent of participants (n= 441) reported dual use of tobacco and any cannabis during the observation period; 9.4% (n= 130) reported daily cannabis use. Among dual users reporting daily cannabis use, 13.9% had a diagnosed cannabis user disorder in the EHR. Neither engagement with quitline counseling nor long-term tobacco abstinence rates differed between those using tobacco-only and either dual-use group (i.e., persons using any cannabis or daily cannabis).ConclusionsDual use of tobacco and cannabis is common among smokers seen in primary care and those enrolling in quitline care, but it may not undermine tobacco quitline engagement or smoking cessation. Opportunities exist in the US to leverage quitlines to identify and intervene with dual users of tobacco and cannabis.HIGHLIGHTS•Tobacco quitline care was equally engaging and effective among tobacco users and dual users of tobacco and cannabis•Many daily cannabis users calling tobacco quitlines likely have a cannabis use disorder•Tobacco quitlines can be leveraged to identify and intervene with dual users of tobacco and cannabis